Saltar al contenido
Merck
Todas las fotos(2)

Key Documents

911925

Sigma-Aldrich

NanoFabTx microfluidic chip

for 1-5 μm particles

Sinónimos:

Microfluidic kit, Microparticle, NanoFabTx, Nanoformulation

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

UNSPSC Code:
41116105
UNSPSC Code:
41121800
NACRES:
NC.25

description

Microfludic hardware kit component for synthesizing 1-5 μm microparticles

Kit components :

  • Microfluidic chip x 1

Quality Level

application(s)

advanced drug delivery

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

NanoFabTx microfluidic chip, for 1-5 μm particles is a component of our NanoFabTx microfluidic - micro, device kit for synthesis of 1-5 µm particles (911860). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

Application

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx microfluidic chip, for 1-5 μm particles can be used as a replacement for the component in our NanoFabTx microfluidic - micro, device kit for synthesis of 1-5 μm particles (911860).

Legal Information

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico